Latest filing published 24 Jul 2020 for Kontafarma China Holdings Ltd.. Read the official filing
No signal scores available.
Zhang Ruibin discloses dealings in Kontafarma China Holdings Ltd. to HKEX. Over a trading history stretching from 3 May 2018 to 22 July 2020, the count stands at 2 filings.
Every open-market trade on record is a sale: 1 sale. The totals exclude 1 filing filed without an amount. Since January 2020: no purchases and 1 sale on the market.
On 24 July 2020 came the latest disclosure, an open-market sale in Kontafarma China Holdings Ltd. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by HKEX. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations